By Tim Fitzgerald* and Michael Finney** — ‘Swiss format’ or ‘Swiss-type’ patent claims have a general structure similar to the following: Use of compound X in the manufacture of a formulation for the treatment of medical condition Y. Swiss-type claims were originally approved by the Swiss Patent Office as a mechanism to allow for protection […]
Read MoreAIPPI conference in London 14-18 September 2019 Wayne Slater will be attending the upcoming AIPPI conference in London on behalf of our firm. Wayne is a member of the AIPPI standing committee on designs and will also be taking the opportunity to meet the UK clients of the firm. This year the world Congress for […]
Read More
The annual BIO International Convention for 2019 will be held at the Pennsylvania Convention Center, Philadelphia where Jack King-Scott will be one of more than 16,000 attendees from 67 countries. The delegates will gather together for unique opportunities for education and networking with some of the global leaders in biotech, pharma and life science. IP Gateway […]
Read More
OPIUM WARS By Alison McMillan PhD The Tasmanian licit opium poppy industry provides about 50% of the world’s Narcotic Raw Material (NRM). The industry is worth about $290 million to Tasmania. The Tasmanian poppy industry is controlled by three companies, SunPharma, India’s largest pharmaceutical company, Tasmanian Alkaloids Pty Ltd (Tas Alkaloids) owned by SK […]
Read More